New Edition of ESMO/ASCO Global Curriculum in Medical Oncology – Setting Standards for Modern Training
ESMO in collaboration with ASCO published today the 2016 edition of the ESMO/ASCO Recommendations for a Global Curriculum (GC) in Medical Oncology
ESMO Media Releases
Ki67 May Help Avoid Sentinel Lymph Node Biopsy in Some Patients
Breast cancer patients over 50 years old could be spared invasive procedures by use of stratification based on tumour size and molecular characteristics, including Ki67
ESMO 2016 Poster Abstracts Published Online Today
Abstracts to be presented as Posters or Poster Discussions at ESMO 2016 Congress will be published online today at 12:00 CEST
Precision Medicine Trial First of its Kind to Show Benefit to Patients
A critical trial for types of advanced cancer is the first of its kind to show that precision medicine can slow down the time it takes for a tumour to grow back
ESMO Announces Press Programme Presenting Latest Cancer Research
Breaking news on innovative cancer treatments will be announced at ESMO 2016, the annual oncology congress organised by the European Society for Medical Oncology, taking place from 7 to 11 October 2016 at Bella Centre in Copenhagen, Denmark.
Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
ESMO launches the first eUpdates for its world-renowned ESMO Clinical Practice Guidelines (CPG)
ESMO Rewards Outstanding Oncologists
The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has revealed the four outstanding recipients of its distinguished awards.
ESMO Publishes Results of European Consortium Study on the Availability of Anti-neoplastic Medicines
A major new study has found substantial differences in the formulary availability, out-of-pocket costs and actual availability of anti-cancer medicines across Europe.
ESMO 2018 Annual Congress to be Held in Munich
We are pleased to announce that the ESMO 2018 Annual Congress will take place between 19-23 October 2018 at the Messe Muenchen, Germany
The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress on Gastrointestinal Cancer
The lively discussion which followed the presentation of ‘A pivotal phase 3 Trial of MABp1 in advanced colorectal cancer'
Results of First Study Assessing Clinical Impact of ESMO-MCBS
Details of the first study by one of Europe’s largest cancer centres, the Medical University of Vienna (MUV), assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale (MCBS) in a real-life context are now available on ESMO Open
ESMO Releases New Consensus Guidelines on the Management of Metastatic Colorectal Cancer
Guidelines reflect personalised treatment approach